HOME › DRUGS › MAVORIXAFOR
ACTIVE SUBSTANCE / INN

MAVORIXAFOR

Brand name(s): XOLREMDI, Xolremdi
FDA LISTED
EMA LISTED
PRESCRIPTION
OPINION
Primary Immunodeficiency Diseases
NDA218709
ACTIVE SUBSTANCE
Mavorixafor
REGULATORS
FDA · EMA
SPONSORS / MAH
X4 Pharmaceuticals GmbH, X4 PHARMS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XOLREMDINDA218709X4 PHARMSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XolremdiX4 Pharmaceuticals GmbHOpinionPrimary Immunodeficiency Diseases

FULL INTELLIGENCE ON MAVORIXAFOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →